161 related articles for article (PubMed ID: 7779716)
1. Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer.
Yamamoto H; Monden T; Ikeda K; Izawa H; Fukuda K; Fukunaga M; Tomita N; Shimano T; Shiozaki H; Monden M
Br J Cancer; 1995 Jun; 71(6):1231-6. PubMed ID: 7779716
[TBL] [Abstract][Full Text] [Related]
2. [RB gene expression in gastrointestinal tract].
Monden T; Yamamoto H; Ikeda K; Izawa H; Tsujie M; Ohnishi T; Miyoshi Y; Sekimoto M; Tomita N; Monden M
Nihon Rinsho; 1996 Apr; 54(4):965-71. PubMed ID: 8920658
[TBL] [Abstract][Full Text] [Related]
3. Behavior of the cell cycle-associated proteins in an unusual G0-arrestable cancer cell line.
Ohta T; Fukuda M; Wanebo HJ; Jogo K; Yamaguchi S
Exp Cell Res; 1996 May; 225(1):85-92. PubMed ID: 8635520
[TBL] [Abstract][Full Text] [Related]
4. Cdk2/cdc2 expression in colon carcinogenesis and effects of cdk2/cdc2 inhibitor in colon cancer cells.
Yamamoto H; Monden T; Miyoshi H; Izawa H; Ikeda K; Tsujie M; Ohnishi T; Sekimoto M; Tomita N; Monden M
Int J Oncol; 1998 Aug; 13(2):233-9. PubMed ID: 9664116
[TBL] [Abstract][Full Text] [Related]
5. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
Musgrove EA; Sarcevic B; Sutherland RL
J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
[TBL] [Abstract][Full Text] [Related]
6. Analysis of phosphorylation of pRB and its regulatory proteins in breast cancer.
Wakasugi E; Kobayashi T; Tamaki Y; Nakano Y; Ito Y; Miyashiro I; Komoike Y; Miyazaki M; Takeda T; Monden T; Monden M
J Clin Pathol; 1997 May; 50(5):407-12. PubMed ID: 9215124
[TBL] [Abstract][Full Text] [Related]
7. Differential cyclin-dependent kinase expression and activation in human colon cancer.
Salh B; Bergman D; Marotta A; Pelech SL
Anticancer Res; 1999; 19(1B):741-8. PubMed ID: 10216486
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
[TBL] [Abstract][Full Text] [Related]
10. Amplified CDK2 and cdc2 activities in primary colorectal carcinoma.
Kim JH; Kang MJ; Park CU; Kwak HJ; Hwang Y; Koh GY
Cancer; 1999 Feb; 85(3):546-53. PubMed ID: 10091728
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
[TBL] [Abstract][Full Text] [Related]
12. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
Panigone S; Debernardi S; Taya Y; Fontanella E; Airoldi R; Delia D
Oncogene; 2000 Aug; 19(35):4035-41. PubMed ID: 10962560
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of the major cyclin-dependent kinases, cdk2 and cdc2, during cell cycle progression in human lymphocytes exposed to heptachlor.
Chuang LF; Rought SE; Chuang RY
In Vivo; 1999; 13(6):455-61. PubMed ID: 10757037
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma.
Li JQ; Miki H; Ohmori M; Wu F; Funamoto Y
Hum Pathol; 2001 Sep; 32(9):945-53. PubMed ID: 11567224
[TBL] [Abstract][Full Text] [Related]
15. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL
Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of cyclins (D1, E, A), cyclin-dependent kinases (CDK2, CDK4) and tumor-suppressor genes (pRB, p16INK4A) in childhood acute lymphoblastic leukemia.
Volm M; Koomägi R; Stammler G; Rittgen W; Zintl F; Sauerbrey A
Int J Cancer; 1997 Oct; 74(5):508-12. PubMed ID: 9355972
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of the retinoblastoma protein by cdk2.
Akiyama T; Ohuchi T; Sumida S; Matsumoto K; Toyoshima K
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):7900-4. PubMed ID: 1518810
[TBL] [Abstract][Full Text] [Related]
18. Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation of an active kinase complex which phosphorylates retinoblastoma gene product in G1.
Joseph LF; Ezhevsky S; Scott DW
Cell Growth Differ; 1995 Jan; 6(1):51-7. PubMed ID: 7718485
[TBL] [Abstract][Full Text] [Related]
19. Expression of G1 cyclins and cyclin-dependent kinase-2 activity during terminal differentiation of cultured human trophoblast.
McKenzie PP; Foster JS; House S; Bukovsky A; Caudle MR; Wimalasena J
Biol Reprod; 1998 May; 58(5):1283-9. PubMed ID: 9603265
[TBL] [Abstract][Full Text] [Related]
20. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
